bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figures S1-S10 from Interleukin-12 from CD103+ Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis
Authors: Mittal Deepak , Vijayan Dipti , Putz Eva M. , Aguilera Amelia R. , Markey Kate A. , Straube Jasmin , Kazakoff Stephen , Nutt Stephen L. , Takeda Kazuyoshi , Hill Geoffrey R. , Waddell Nicola , Smyth Mark J.
Published: April 2023

Supplementary Figure 1. Primary tumor growth is not dependent on Batf3-dependent DCs. Supplementary Figure 2. Increased NK cell infiltration in the lungs of WT mice injected with B16F10 melanoma cells. Supplementary Figure 3. NK cell homeostasis is normal in Batf3-deficient mice. Supplementary Figure S4. Batf3 deficiency is not critical for NK cell responses to LPS. Supplementary Figure 5. Batf3-deficient NK cells retain their anti-metastatic activity and cytotoxicity. Supplementary Figure 6. Batf3-dependent DCs in lungs and mixed chimerism after BM reconstitution. Supplementary Figure S7. IL-12 from CD103+ Batf3-dependent DCs stimulates NK cell IFN-γ production. Supplementary Figure 8. BATF3, CD103 and IRF8 correlation with relapse-free survival in Grade 1- 3 breast cancer patients. Supplementary Figure 9. BATF3 and IRF correlation with DC markers in breast cancers. Supplementary Figure 10. Pairwise correlation plot of BATF3 and IRF8 and other DCs and NK cell-associated genes in breast cancers using TCGA breast RNAseq data.
Supplemental Table 3 from Clinical Response of a Patient to Anti–PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors
Authors: Shah Shalin , Ward James E. , Bao Riyue , Hall Curtis R. , Brockstein Bruce E. , Luke Jason J.
Published: April 2023

Significant biological processes (FDR<0.05) enriched in the 1,015 genes co-clustered with known T cell gene signatures. Among 1,015 genes, 771 were associated with GO annotation in DAVID database v6.7. Count: number of genes from my list that are associated with this GO term. List Total: total number of genes in my list. Pop Hits: total number of genes associated with this GO term from the database. Pop Total: total number of genes in the database. Fold Enrichment: relative enrichment ratio, calculated by (Count)/(List Total) divided by (Pop Hits)/(Pop Total).
Supplementary Figure 3 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Authors: Vandeveer Amanda J. , Fallon Jonathan K. , Tighe Robert , Sabzevari Helen , Schlom Jeffrey , Greiner John W.
Published: April 2023

PD-L1 expression levels on mouse bladders containing MB49 tumors and on normal mouse bladders.
Supplementary Movie 5 from CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
Authors: Davenport Alexander J. , Jenkins Misty R. , Cross Ryan S. , Yong Carmen S. , Prince H. Miles , Ritchie David S. , Trapani Joseph A. , Kershaw Michael H. , Darcy Phillip K. , Neeson Paul J.
Published: April 2023

Movie 5. Serial killing of tumor targets by CAR.OT-I effector cells following engagement through the CAR
Supplementary Figure 1 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Authors: Vandeveer Amanda J. , Fallon Jonathan K. , Tighe Robert , Sabzevari Helen , Schlom Jeffrey , Greiner John W.
Published: April 2023

Flow cytometric analyses depicting the percentage of splenocytes from mice that express CD4 or CD8 indicating the two T cell subsets.
Supplementary Figure 4 from Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes
Authors: Kitano Shigehisa , Postow Michael A. , Ziegler Carly G.K. , Kuk Deborah , Panageas Katherine S. , Cortez Czrina , Rasalan Teresa , Adamow Mathew , Yuan Jianda , Wong Philip , Altan-Bonnet Gregoire , Wolchok Jedd D. , Lesokhin Alexander M.
Published: April 2023

PDF file - 101K, Supplemental Figure 4. Different summary statistics can be applied to measure HLA-DR expression on lineage negative, CD14+CD11b+ cells and assess relationship to overall survival (using maximum logrank statistics as described in Methods). CV was used as a self-normalizing measurement that was preferred to eliminate non-biological variation in clinical measurements (e.g. day-to-day variation, differences in sample handling and FACS acquisition).
Supplementary Figures Legends from T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine
Authors: Dennis Kristen L. , Saadalla Abdulrahman , Blatner Nichole R. , Wang Shuya , Venkateswaran Vysak , Gounari Fotini , Cheroutre Hilde , Weaver Casey T. , Roers Axel , Egilmez Nejat K. , Khazaie Khashayarsha
Published: April 2023

Legends to Supplementary Figures
Supplementary Figure 3 from T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine
Authors: Dennis Kristen L. , Saadalla Abdulrahman , Blatner Nichole R. , Wang Shuya , Venkateswaran Vysak , Gounari Fotini , Cheroutre Hilde , Weaver Casey T. , Roers Axel , Egilmez Nejat K. , Khazaie Khashayarsha
Published: April 2023

APCdelta468 small intestine serial sections were stained for rabbit anti-mouse granzyme B or isotype control (rabbit IgG) and identified using anti-rabbit Alexa-Fluor 594 secondary antibody. Sections were counterstained with DAPI.
Supplementary Figure S1 from IL17A-Mediated Endothelial Breach Promotes Metastasis Formation
Authors: Kulig Paulina , Burkhard Sara , Mikita-Geoffroy Joanna , Croxford Andrew L. , Hövelmeyer Nadine , Gyülvészi Gabor , Gorzelanny Christian , Waisman Ari , Borsig Lubor , Becher Burkhard
Published: April 2023

Supplementary Figure S1
Supplemental Figure Legends from Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
Authors: Dammeijer Floris , Lievense Lysanne A. , Kaijen-Lambers Margaretha E. , van Nimwegen Menno , Bezemer Koen , Hegmans Joost P. , van Hall Thorbald , Hendriks Rudi W. , Aerts Joachim G.
Published: April 2023

Supplemental Figure Legends 1-7
Figure S1 from Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Authors: Kouo Theodore , Huang Lanqing , Pucsek Alexandra B. , Cao Minwei , Solt Sara , Armstrong Todd , Jaffee Elizabeth
Published: April 2023

In A-D) Western blots showing vaccine-specific sera reactive responses in all 60 vaccinated patients and 22 healthy donors. In E-F) Identification of antibody-reactive proteins by serological proteomics. G-I) Antibody responses to influenza proteins analyzed from the same sera shown for galectin-3 titers are intact and unaffected by multiple immunotherapy treatments in vaccinated patients.
Supplementary Table S1 from Molecular Drivers of the Non–T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Authors: Sweis Randy F. , Spranger Stefani , Bao Riyue , Paner Gladell P. , Stadler Walter M. , Steinberg Gary , Gajewski Thomas F.
Published: April 2023

Differentially expressed genes in non-T cell-inflamed vs. T cell-inflamed tumors
Supplementary Figure S1 from Molecular Drivers of the Non–T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Authors: Sweis Randy F. , Spranger Stefani , Bao Riyue , Paner Gladell P. , Stadler Walter M. , Steinberg Gary , Gajewski Thomas F.
Published: April 2023

Correlative plots depicting the relationship between expression of CCL4 and BATF3 with CD8A, WNT7B, and PPARG
Supplementary Figure S2 from Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib
Authors: Frazao Alexandra , Colombo Marina , Fourmentraux-Neves Emmanuelle , Messaoudene Meriem , Rusakiewicz Sylvie , Zitvogel Laurence , Vivier Eric , Vély Frédéric , Faure Florence , Dréno Brigitte , Benlalam Houssem , Bouquet Fanny , Savina Ariel , Pasmant Eric , Toubert Antoine , Avril Marie-Françoise , Caignard Anne
Published: April 2023

Phenotype and degranulation potential of IL-15 activated NK cells
Supplementary Figure 2 from The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
Authors: Swierczak Agnieszka , Cook Andrew D. , Lenzo Jason C. , Restall Christina M. , Doherty Judy P. , Anderson Robin L. , Hamilton John A.
Published: April 2023

PDF file - 406K, Supplementary Figure 2: Changes in Ly6Chi monocytes are lost when assessing FACS percentages when compared to total cell counts.
Supplementary Figure 2 from Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy
Authors: Campa Michael J. , Gottlin Elizabeth B. , Bushey Ryan T. , Patz Edward F.
Published: April 2023

Deposition of C3-related fragments on A549 lung cancer cells.
Supplementary Figures 1 - 5, Tables 1, 5 - 9 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
Authors: Zhang Xiuli , Kim Samuel , Hundal Jasreet , Herndon John M. , Li Shunqiang , Petti Allegra A. , Soysal Savas D. , Li Lijin , McLellan Mike D. , Hoog Jeremy , Primeau Tina , Myers Nancy , Vickery Tammi L. , Sturmoski Mark , Hagemann Ian S. , Miller Chris A. , Ellis Matthew J. , Mardis Elaine R. , Hansen Ted , Fleming Timothy P. , Goedegebuure S. Peter , Gillanders William E.
Published: April 2023

Supplementary Figure 1. H&E of WHIM30, WHIM35 and WHIM37 parental tumors. Supplementary Figure 2. Peptides corresponding to prioritized neoantigens can induce strong surface expression of HLA class I molecules. Supplementary Figure 3. Indirect tumor-specific immune response. Supplementary Figure 4. The immune response to neoantigens is HLA-specific. Supplementary Figure 5. Prioritized neoantigens induce immune responses in HLA-A0201 transgenic. Supplementary Table 1. Patient clinical characteristics. Supplementary Table 5. Summary of candidate neoantigens identified by exome sequencing. Supplementary Table 6. HLA typing. Supplementary Table 7. Candidate neoantigens and HLA class I predicted binding affinities for WHIM30. Supplementary Table 8. Candidate neoantigens and HLA class I predicted binding affinities for WHIM35.
Supplementary Fig. S.7 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

MG1-IL12-ICV vaccine enhances natural killer cell recruitment and function via dendritic cells.
Supplementary Fig. S.6 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

Cytotoxicity of human NK cells derived from healthy individual and cancer patients.
Supplementary Figure 4 from Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Authors: Jeanbart Laura , Ballester Marie , de Titta Alexandre , Corthésy Patricia , Romero Pedro , Hubbell Jeffrey A. , Swartz Melody A.
Published: April 2023

PDF file - 22K, Targeting the tdLN with NP-OVA and NP-CpG induces more antigen-specific and effector CD8+ T cells in the tumor, spleen, and tdLN.
Supplementary Figure 1 from Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Authors: Jeanbart Laura , Ballester Marie , de Titta Alexandre , Corthésy Patricia , Romero Pedro , Hubbell Jeffrey A. , Swartz Melody A.
Published: April 2023

PDF file - 37K, NPs target the tdLN.
supplementary table 3 from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Table S3. Expression of CD204 in 121 gastric tumors according to tumor stages
Supplemental Figure 1 from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade
Authors: Curran Shane A. , Shyer Justin A. , St. Angelo Erin T. , Talbot Lillian R. , Sharma Sneh , Chung David J. , Heller Glenn , Hsu Katharine C. , Betts Brian C. , Young James W.
Published: April 2023

TG101348 and ruxolitinib inhibit JAK2 mediated STAT5 and STAT3 phosphorylation.
Figure S1 from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Supplementary Figure S1. The level of M2 macrophages is higher in the advanced-stage gastric tumors than in the early-stage gastric tumors. Expression of CD68 (macrophage marker) and CD204 (M2 marker) was analyzed by IHC staining in 121 gastric tumors. A, the bar graph depicts the average percentages of IHC staining for CD68 in the early- and advanced-stage gastric tumors. B, the bar graph depicts the average percentages of IHC staining for CD204 in the early- and advanced-stage gastric tumors. *** P < 0.001 versus early-stage tumors, Student's t test.
Supplementary Tables from Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Authors: Christmas Brian J. , Rafie Christine I. , Hopkins Alexander C. , Scott Blake A. , Ma Hayley S. , Cruz Kayla A. , Woolman Skylar , Armstrong Todd D. , Connolly Roisin M. , Azad Nilo A. , Jaffee Elizabeth M. , Roussos Torres Evanthia T.
Published: April 2023

The supplemental tables include: antibodies used for flow cytometry; gene expression of genes involved in innate and adaptive immunity from whole tumors isolated from neu-N mice.
Supplementary Tables S1-S2 from TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
Authors: Josefsson Sarah E. , Beiske Klaus , Blaker Yngvild N. , Førsund Mette S. , Holte Harald , Østenstad Bjørn , Kimby Eva , Köksal Hakan , Wälchli Sébastien , Bai Baoyan , Smeland Erlend B. , Levy Ronald , Kolstad Arne , Huse Kanutte , Myklebust June H.
Published: April 2023

Supplementary Table S1-S2.
Supplementary Data from Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer
Authors: O'Malley Grace , Treacy Oliver , Lynch Kevin , Naicker Serika D. , Leonard Niamh A. , Lohan Paul , Dunne Philip D. , Ritter Thomas , Egan Laurence J. , Ryan Aideen E.
Published: April 2023

Characterisation of primary BALB/c MSCs isolated from bone marrow, PD-L1 induction on MSC TNF-TCM is dependent on CT26 NF-κB activity, Validation of scrambled and PD-L1 shRNA transduced Balb/c MSCs - GFP expression and PD-L1 inhibition, Tumour burden following co-administration of either MSCcontrol, MSCTNF-α or MSCTCM, Gating strategy used to analyse CD3, CD4, CD8 and Granzyme B expressing cells in the tumours recovered from animals at Day 21, Dose dependent effects of CT26 co-administered with low and high doses of MSC, Pairwise analysis of relative PD-L1 gene expression between normal and cancer-associated fibroblasts from patients with CRC
Table S1 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Comparison of the numbers and percentages of CD4 and CD8 T cells in the spleens and mesenteric lymph nodes of wild-type and gp96-KO mice.
Supplementary Figure 5 from IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Authors: Mirlekar Bhalchandra , Michaud Daniel , Searcy Ryan , Greene Kevin , Pylayeva-Gupta Yuliya
Published: April 2023

This Figure documents successful depletion of CD8 T cells from mice, and shows results of tumor growth studies on mice with IL35 deficiency and treated with anti-PD1
Supplementary Figure 8 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

E-cadherin expression and Jak mutational status of LLC cells
Supplementary Figure 5 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Flow cytometry gating strategy for identifying CD4+ and CD8+ T cells
Supplemental figure legends and table from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Authors: Kim Min Hwan , Kim Chang Gon , Kim Sang-Kyum , Shin Sang Joon , Choe Eun Ah , Park Su-Hyung , Shin Eui-Cheol , Kim Joon
Published: April 2023

Supplementary figure legends and Supplementary tables
Suppl Figure 4 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
Authors: Solomon Benjamin , Young Richard J. , Bressel Mathias , Urban Damien , Hendry Shona , Thai Alesha , Angel Christopher , Haddad Afaf , Kowanetz Marcin , Fua Tsien , Corry June , Fox Stephen , Rischin Danny
Published: April 2023

Staging Methods KM curves
Supplementary Data from Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma
Authors: Yusko Erik , Vignali Marissa , Wilson Richard K. , Mardis Elaine R. , Hodi F. Stephen , Horak Christine , Chang Han , Woods David M. , Robins Harlan , Weber Jeffrey
Published: April 2023

Supplementary figures 1-6
Supplementary Table S1 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Human tumor cell lines used in this study.
Supplementary Figure S6 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Down-regulation of STAT3 does not impact IDO1 expression in KUL98-MELA cells and SKOV3 cells.
Supplemental Figures and Legends 1-4 from Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity
Authors: Horton Brendan L. , Williams Jason B. , Cabanov Alexandra , Spranger Stefani , Gajewski Thomas F.
Published: April 2023

Four supplemental figures and their legends.
Figure S5 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
Authors: Beavis Paul A. , Henderson Melissa A. , Giuffrida Lauren , Davenport Alexander J. , Petley Emma V. , House Imran G. , Lai Junyun , Sek Kevin , Milenkovski Nicole , John Liza B. , Mardiana Sherly , Slaney Clare Y. , Trapani Joseph A. , Loi Sherene , Kershaw Michael H. , Haynes Nicole M. , Darcy Phillip K.
Published: April 2023

Supplementary Figure 5
Supplementary Figure 5 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 5
Figure S3 from Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Authors: Polesso Fanny , Weinberg Andrew D. , Moran Amy E.
Published: April 2023

Figure S3 shows the therapeutic efficacy of combination therapy in the absence of CD4 or CD8 T cells.
Supplementary Figures and Tables from Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Authors: Smith Christof C. , Chai Shengjie , Washington Amber R. , Lee Samuel J. , Landoni Elisa , Field Kevin , Garness Jason , Bixby Lisa M. , Selitsky Sara R. , Parker Joel S. , Savoldo Barbara , Serody Jonathan S. , Vincent Benjamin G.
Published: April 2023

Supplemental figures and tables
Supplementary Figure 3 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 3
Supplementary Figure legends from IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Authors: Shao Lulu , Hou Weizhou , Scharping Nicole E. , Vendetti Frank P. , Srivastava Rashmi , Roy Chandra Nath , Menk Ashley V. , Wang Yiyang , Chauvin Joe-Marc , Karukonda Pooja , Thorne Stephen H. , Hornung Veit , Zarour Hassane M. , Bakkenist Christopher J. , Delgoffe Greg M. , Sarkar Saumendra N.
Published: April 2023

Supplementary Figure legends
Supplementary Figure Legend from Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Authors: Danilova Ludmila , Ho Won Jin , Zhu Qingfeng , Vithayathil Teena , De Jesus-Acosta Ana , Azad Nilofer S. , Laheru Daniel A. , Fertig Elana J. , Anders Robert , Jaffee Elizabeth M. , Yarchoan Mark
Published: April 2023

Supplementary Figure Legend
Supplementary Table 2 from MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma
Authors: Vignard Virginie , Labbé Maureen , Marec Nadège , André-Grégoire Gwennan , Jouand Nicolas , Fonteneau Jean-François , Labarrière Nathalie , Fradin Delphine
Published: April 2023

Supplementary Table 2
Supplementary Data from Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set
Authors: Bonsack Maria , Hoppe Stephanie , Winter Jan , Tichy Diana , Zeller Christine , Küpper Marius D. , Schitter Eva C. , Blatnik Renata , Riemer Angelika B.
Published: April 2023

This file contains the combined supplementary figures and tables. Table S1. Prediction methods used in this study. Table S2. In silico predicted and in vitro validated binding affinities of peptides derived from HPV16 E6 and E7 proteins for the HLA types A1, A2, A3, A11, A24, B7 and B15. Figure S1. Performance evaluation of HLA binding prediction algorithms: the capacity to separate HLA-A1, A11, B7 and B15 binders from non-binders. Figure S2. Performance evaluation for the predictor SYFPEITII. Figure S3. Decision threshold-dependent performance analysis of indicated HLA-binding prediction methods for HLA-A1, A11, B7 and B15. Figure S4. Assessment of prediction performance for HLA-A1, A3, A11, A24, B7 and B15 using thresholds individually recommended for each HLA-type and peptide length vs. general intermediate and low binding affinity thresholds. Figure S5. Comparison of prediction accuracies obtained by applying criteria-based and bootstrapping-validated thresholds for each analyzed predictor for HLA-A1, A11, B7 and B15. Figure S6. Effect of using individually calculated criteria-based thresholds vs. commonly used thresholds for the prediction of HPV16 E6 and E7 derived ligands to HLA A1, A3, A11, A24, B7 and B15. Figure S7. Peptide sequence motifs of HLA-type- specific epitope entries from the immune epitope data base (IEDB) and the HPV dataset.
Supplementary Data from Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis
Authors: Harmon Cathal , Robinson Mark W. , Hand Fiona , Almuaili Dalal , Mentor Keno , Houlihan Diarmaid D. , Hoti Emir , Lynch Lydia , Geoghegan Justin , O'Farrelly Cliona
Published: April 2023

Supplemental figures 1-7 and figure legends
Supplementary Figure from CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer
Authors: Maeda Shingo , Murakami Kohei , Inoue Akiko , Yonezawa Tomohiro , Matsuki Naoaki
Published: April 2023

Supplementary Figure from CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer
Supplementary Table 1 from An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
Authors: Guo Jitao , Muse Elena , Christians Allison J. , Swanson Steven J. , Davila Eduardo
Published: April 2023

Supplementary Data Table
Supplementary Data from ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome
Authors: Oh Claire Y. , Klatt Martin G. , Bourne Christopher , Dao Tao , Dacek Megan M. , Brea Elliott J. , Mun Sung Soo , Chang Aaron Y. , Korontsvit Tatyana , Scheinberg David A.
Published: April 2023

Supplemental Figures and Table
Supplementary Table S4 from Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
Authors: Ree Anne Hansen , Nygaard Vigdis , Russnes Hege G. , Heinrich Daniel , Nygaard Vegard , Johansen Christin , Bergheim Inger Riise , Hovig Eivind , Beiske Klaus , Negård Anne , Børresen-Dale Anne-Lise , Flatmark Kjersti , Mælandsmo Gunhild M.
Published: April 2023

Supplementary Table S4
Supplementary Figures 1-8 from Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
Authors: Haas Quentin , Boligan Kayluz Frias , Jandus Camilla , Schneider Christoph , Simillion Cedric , Stanczak Michal A. , Haubitz Monika , Seyed Jafari Seyed Morteza , Zippelius Alfred , Baerlocher Gabriela M. , Läubli Heinz , Hunger Robert E. , Romero Pedro , Simon Hans-Uwe , von Gunten Stephan
Published: April 2023

Supplementary Figures 1-8
Supplementary Figure 2 from CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Authors: Dumont Clement , Jacquier Alix , Verine Jerome , Noel Floriane , Goujon Annabelle , Wu Ching-Lien , Hung Tzu-Min , Desgrandchamps François , Culine Stephane , Carosella Edgardo D. , Rouas-Freiss Nathalie , LeMaoult Joel
Published: April 2023

Control of non-presence of peripheral subpopulations among the tumor infiltrate
Supplementary Figure 1 from CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Authors: Dumont Clement , Jacquier Alix , Verine Jerome , Noel Floriane , Goujon Annabelle , Wu Ching-Lien , Hung Tzu-Min , Desgrandchamps François , Culine Stephane , Carosella Edgardo D. , Rouas-Freiss Nathalie , LeMaoult Joel
Published: April 2023

ILT2 and HLA-G expression of THP1 and THP1-G1
Supplementary Figures and Legends from Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer
Authors: Gurjao Carino , Liu David , Hofree Matan , AlDubayan Saud H. , Wakiro Isaac , Su Mei-Ju , Felt Kristen , Gjini Evisa , Brais Lauren K. , Rotem Asaf , Rosenthal Michael H. , Rozenblatt-Rosen Orit , Rodig Scott , Ng Kimmie , Van Allen Eliezer M. , Corsello Steven M. , Ogino Shuji , Regev Aviv , Nowak Jonathan A. , Giannakis Marios
Published: April 2023

Supplementary Figures 1 and 2
Chafe et al Supplementary Materials and Methods from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Authors: Chafe Shawn C. , McDonald Paul C. , Saberi Saeed , Nemirovsky Oksana , Venkateswaran Geetha , Burugu Samantha , Gao Dongxia , Delaidelli Alberto , Kyle Alastair H. , Baker Jennifer H.E. , Gillespie Jordan A. , Bashashati Ali , Minchinton Andrew I. , Zhou Youwen , Shah Sohrab P. , Dedhar Shoukat
Published: April 2023

Supplementary Materials and Methods
Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Authors: Chafe Shawn C. , McDonald Paul C. , Saberi Saeed , Nemirovsky Oksana , Venkateswaran Geetha , Burugu Samantha , Gao Dongxia , Delaidelli Alberto , Kyle Alastair H. , Baker Jennifer H.E. , Gillespie Jordan A. , Bashashati Ali , Minchinton Andrew I. , Zhou Youwen , Shah Sohrab P. , Dedhar Shoukat
Published: April 2023

Supplementary Figures S1-S6 and Tables S1-S4
Supplementary Figure Legends from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Authors: Wijewarnasuriya Dinali , Bebernitz Christina , Lopez Andrea V. , Rafiq Sarwish , Brentjens Renier J.
Published: April 2023

Figure Legends
Supplementary Tables from CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis
Authors: Lonardi Silvia , Scutera Sara , Licini Sara , Lorenzi Luisa , Cesinaro Anna Maria , Gatta Luisa Benerini , Castagnoli Carlotta , Bollero Daniele , Sparti Rosaria , Tomaselli Michela , Medicina Daniela , Calzetti Federica , Cassatella Marco Antonio , Facchetti Fabio , Musso Tiziana , Vermi William
Published: April 2023

Supplementary Tables 1-2
Supplementary Data from An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients
Authors: Veeramani Suresh , Blackwell Sue E. , Thiel William H. , Yang Zhi-Zhang , Ansell Stephen M. , Giangrande Paloma H. , Weiner George J.
Published: April 2023

Contains Supplementary Figures, Supplementary Methods and Supplementary Tables
Figure S3 from Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
Authors: Paolini Léa , Adam Clément , Beauvillain Céline , Preisser Laurence , Blanchard Simon , Pignon Pascale , Seegers Valérie , Chevalier Louise-Marie , Campone Mario , Wernert Romuald , Verrielle Véronique , Raro Pedro , Ifrah Norbert , Lavoué Vincent , Descamps Philippe , Morel Alain , Catros Véronique , Tcherkez Guillaume , Lenaers Guy , Bocca Cinzia , Kouassi Nzoughet Judith , Procaccio Vincent , Delneste Yves , Jeannin Pascale
Published: April 2023

Figure S3
Supplementary Table 2 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
Authors: Sainson Richard C.A. , Thotakura Anil K. , Kosmac Miha , Borhis Gwenoline , Parveen Nahida , Kimber Rachael , Carvalho Joana , Henderson Simon J. , Pryke Kerstin L. , Okell Tracey , O'Leary Siobhan , Ball Stuart , Van Krinks Cassie , Gamand Lauriane , Taggart Emma , Pring Eleanor J. , Ali Hanif , Craig Hannah , Wong Vivian W.Y. , Liang Qi , Rowlands Robert J. , Lecointre Morgane , Campbell Jamie , Kirby Ian , Melvin David , Germaschewski Volker , Oelmann Elisabeth , Quaratino Sonia , McCourt Matthew
Published: April 2023

Metadata for the 5 NSCLC patients
Supplementary Tables from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival
Authors: Gherardin Nicholas A. , Waldeck Kelly , Caneborg Alex , Martelotto Luciano G. , Balachander Shiva , Zethoven Magnus , Petrone Pasquale M. , Pattison Andrew , Wilmott James S. , Quiñones-Parra Sergio M. , Rossello Fernando , Posner Atara , Wong Annie , Weppler Alison M. , Shannon Kerwin F. , Hong Angela , Ferguson Peter M. , Jakrot Valerie , Raleigh Jeanette , Hatzimihalis Athena , Neeson Paul J. , Deleso Paolo , Johnston Meredith , Chua Margaret , Becker Juergen C. , Sandhu Shahneen , McArthur Grant A. , Gill Anthony J. , Scolyer Richard A. , Hicks Rodney J. , Godfrey Dale I. , Tothill Richard W.
Published: April 2023

Supplementary Tables
Supplementary Figures from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival
Authors: Gherardin Nicholas A. , Waldeck Kelly , Caneborg Alex , Martelotto Luciano G. , Balachander Shiva , Zethoven Magnus , Petrone Pasquale M. , Pattison Andrew , Wilmott James S. , Quiñones-Parra Sergio M. , Rossello Fernando , Posner Atara , Wong Annie , Weppler Alison M. , Shannon Kerwin F. , Hong Angela , Ferguson Peter M. , Jakrot Valerie , Raleigh Jeanette , Hatzimihalis Athena , Neeson Paul J. , Deleso Paolo , Johnston Meredith , Chua Margaret , Becker Juergen C. , Sandhu Shahneen , McArthur Grant A. , Gill Anthony J. , Scolyer Richard A. , Hicks Rodney J. , Godfrey Dale I. , Tothill Richard W.
Published: April 2023

Supplementary Figures
Supplemental Figures from Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity
Authors: Khojandi Niloufar , Kuehm Lindsey M. , Piening Alexander , Donlin Maureen J. , Hsueh Eddy C. , Schwartz Theresa L. , Farrell Kaitlin , Richart John M. , Geerling Elizabeth , Pinto Amelia K. , George Sarah L. , Albert Carolyn J. , Ford David A. , Chen Xiufen , Kline Justin , Teague Ryan M.
Published: April 2023

Supplemental Figures S1-S7
Supplementary Figure S1 from Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
Authors: Lauret Marie Joseph Elodie , Laheurte Caroline , Jary Marine , Boullerot Laura , Asgarov Kamal , Gravelin Eléonore , Bouard Adeline , Rangan Laurie , Dosset Magalie , Borg Christophe , Adotévi Olivier
Published: April 2023

Expression of TIE2 receptor by M-MDSCs.
Supplementary Tables from B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
Authors: Mirlekar Bhalchandra , Michaud Daniel , Lee Samuel J. , Kren Nancy P. , Harris Cameron , Greene Kevin , Goldman Emily C. , Gupta Gaorav P. , Fields Ryan C. , Hawkins William G. , DeNardo David G. , Rashid Naim U. , Yeh Jen Jen , McRee Autumn J. , Vincent Benjamin G. , Vignali Dario A.A. , Pylayeva-Gupta Yuliya
Published: April 2023

Supplementary Tables 1-3
Supplementary Figure Legend from Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer
Authors: De Martino Mara , Daviaud Camille , Diamond Julie M. , Kraynak Jeffrey , Alard Amandine , Formenti Silvia C. , Miller Lance D. , Demaria Sandra , Vanpouille-Box Claire
Published: April 2023

Supplementary Figure Legend
Supplementary Table 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
Authors: Rajamanickam Venkatesh , Ballesteros-Merino Carmen , Samson Kimberly , Ross David , Bernard Brady , Fox Bernard A. , Tran Eric , Newell Pippa , Duhen Thomas
Published: April 2023

Supplementary Table 1
Supplementary Figure 2 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
Authors: Rajamanickam Venkatesh , Ballesteros-Merino Carmen , Samson Kimberly , Ross David , Bernard Brady , Fox Bernard A. , Tran Eric , Newell Pippa , Duhen Thomas
Published: April 2023

Expression levels of genes involved in the MHC class I pathway in the primary tumor and CRLM of patient CRI 3280
Supplementary Figure 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
Authors: Rajamanickam Venkatesh , Ballesteros-Merino Carmen , Samson Kimberly , Ross David , Bernard Brady , Fox Bernard A. , Tran Eric , Newell Pippa , Duhen Thomas
Published: April 2023

Phenotypic analysis of the CD4 compartment in patients with CRLM
Supplementary Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
Authors: Deligne Claire , Murdamoothoo Devadarssen , Gammage Anís N. , Gschwandtner Martha , Erne William , Loustau Thomas , Marzeda Anna M. , Carapito Raphael , Paul Nicodème , Velazquez-Quesada Inés , Mazzier Imogen , Sun Zhen , Orend Gertraud , Midwood Kim S.
Published: April 2023

Supplementary figures and table
Supplementary Figures and Tables from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
Authors: Prota Gennaro , Gileadi Uzi , Rei Margarida , Lechuga-Vieco Ana Victoria , Chen Ji-Li , Galiani Silvia , Bedard Melissa , Lau Vivian Wing Chong , Fanchi Lorenzo F. , Artibani Mara , Hu Zhiyuan , Gordon Siamon , Rehwinkel Jan , Enríquez Jose A. , Ahmed Ahmed A. , Schumacher Ton N. , Cerundolo Vincenzo
Published: April 2023

Supplementary Figures 1-8 and Tables 1-2
Supplementary Data from Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors
Authors: Garrido Greta , Schrand Brett , Levay Agata , Rabasa Ailem , Ferrantella Anthony , Da Silva Diane M. , D'Eramo Francesca , Marijt Koen A. , Zhang Zhuoran , Kwon Deukwoo , Kortylewski Marcin , Kast W. Martin , Dudeja Vikas , van Hall Thorbald , Gilboa Eli
Published: April 2023

Supplementary Figures and Table
Figure S2 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
Authors: Capietto Aude-Hélène , Lee Seunghyun , Clever David , Eul Emily , Ellis Haley , Ma Cynthia X. , Faccio Roberta
Published: April 2023

In vivo anti-Gr1 Ab treatment fails to deplete CD11b+/Gr1+ myeloid cells in bone marrow of mice with skeletal tumors
Table S8 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Table S8
Table S11 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Table S11
Movie 7 from Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery
Authors: Slaats Jeroen , Dieteren Cindy E. , Wagena Esther , Wolf Louis , Raaijmakers Tonke K. , van der Laak Jeroen A. , Figdor Carl G. , Weigelin Bettina , Friedl Peter
Published: April 2023

Single CTL-associated MEC1/OVA Ca2+ event followed by target cell death in control culture (DMSO) and lack of CTL-associated MEC1/OVA Ca2+ events despite stable CTL-target cell interactions in the presence of BTP2. Arrowhead highlights the CTL-associated MEC1/OVA Ca2+ event. Time stamp, h:min. Fire LUT, Ca2+ intensity. Scale bar, 10 µm.
Video 2 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Authors: Wellinger Lisa C. , Hogg Simon J. , Newman Dane M. , Friess Thomas , Geiss Daniela , Michie Jessica , Ramsbottom Kelly M. , Bacac Marina , Fauti Tanja , Marbach Daniel , Jarassier Laura , Thienger Phillip , Paehler Axel , Cluse Leonie A. , Kearney Conor J. , Vervoort Stephin J. , Trapani Joseph A. , Oliaro Jane , Shortt Jake , Ruefli-Brasse Astrid , Rohle Daniel , Johnstone Ricky W.
Published: April 2023

Supp Video 2
Video 1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Authors: Wellinger Lisa C. , Hogg Simon J. , Newman Dane M. , Friess Thomas , Geiss Daniela , Michie Jessica , Ramsbottom Kelly M. , Bacac Marina , Fauti Tanja , Marbach Daniel , Jarassier Laura , Thienger Phillip , Paehler Axel , Cluse Leonie A. , Kearney Conor J. , Vervoort Stephin J. , Trapani Joseph A. , Oliaro Jane , Shortt Jake , Ruefli-Brasse Astrid , Rohle Daniel , Johnstone Ricky W.
Published: April 2023

Supp Video 1
Supplementary Data from Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
Authors: Celus Ward , Oliveira Ana I. , Rivis Silvia , Van Acker Heleen H. , Landeloos Ewout , Serneels Jens , Cafarello Sarah Trusso , Van Herck Yannick , Mastrantonio Roberta , Köhler Arnaud , Garg Abhishek D. , Flamand Véronique , Tamagnone Luca , Marine Jean-Christophe , Matteo Mario Di , Costa Bruno M. , Bechter Oliver , Mazzone Massimiliano
Published: April 2023

Supplementary Data from Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
Supplementary Data from Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling
Authors: Lin Regina J. , Nager Andrew R. , Park Spencer , Sutton Janette , Lay Cecilia , Melton Zea , Zhang Yi , Boldajipour Bijan , Blarcom Thomas J. Van , Panowski Siler H. , Sasu Barbra J. , Chaparro-Riggers Javier
Published: April 2023

Supplementary Data from Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling
Supplementary Table from A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types
Authors: Bugatti Mattia , Bergamini Marco , Missale Francesco , Monti Matilde , Ardighieri Laura , Pezzali Irene , Picinoli Sara , Caronni Nicoletta , Missolo-Koussou Yoann , Helft Julie , Benvenuti Federica , Vermi William
Published: April 2023

Supplementary Table from A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types
Supplementary Table from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
Authors: Liu Heng , Lin Jianhuang , Zhou Wei , Moses Renyta , Dai Zhongping , Kossenkov Andrew V. , Drapkin Ronny , Bitler Benjamin G. , Karakashev Sergey , Zhang Rugang
Published: April 2023

Supplementary Table from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
Supplementary Figure from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
Authors: Liu Heng , Lin Jianhuang , Zhou Wei , Moses Renyta , Dai Zhongping , Kossenkov Andrew V. , Drapkin Ronny , Bitler Benjamin G. , Karakashev Sergey , Zhang Rugang
Published: April 2023

Supplementary Figure from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
Supplementary Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
Authors: Thudium Kent , Selby Mark , Zorn Julie A. , Rak Gregory , Wang Xi-Tao , Bunch Roderick Todd , Hogan Jason M. , Strop Pavel , Korman Alan J.
Published: April 2023

Supplementary Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
Supplementary Tables from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Authors: Lin Tongtong , Hu Liang , Hu Fan , Li Kun , Wang Chao-Yu , Zong Li-Juan , Zhao Ya-Qian , Zhang Xiaotao , Li Yan , Yang Yang , Wang Yu , Jiang Chun-Yi , Wu Xuefeng , Liu Wen-Tao
Published: April 2023

Supplementary Tables
Supplementary Figures from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Authors: Lin Tongtong , Hu Liang , Hu Fan , Li Kun , Wang Chao-Yu , Zong Li-Juan , Zhao Ya-Qian , Zhang Xiaotao , Li Yan , Yang Yang , Wang Yu , Jiang Chun-Yi , Wu Xuefeng , Liu Wen-Tao
Published: April 2023

Supplementary Figures 1-11
Supplementary Data from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Authors: Lin Tongtong , Hu Liang , Hu Fan , Li Kun , Wang Chao-Yu , Zong Li-Juan , Zhao Ya-Qian , Zhang Xiaotao , Li Yan , Yang Yang , Wang Yu , Jiang Chun-Yi , Wu Xuefeng , Liu Wen-Tao
Published: April 2023

Supplementary Data from NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
Supplementary Figure from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
Authors: Wakiyama Hiroaki , Kato Takuya , Furusawa Aki , Okada Ryuhei , Inagaki Fuyuki , Furumoto Hideyuki , Fukushima Hiroshi , Okuyama Shuhei , Choyke Peter L. , Kobayashi Hisataka
Published: April 2023

Supplementary Figure from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
Supplemental Video from Syntaphilin Regulates Neutrophil Migration in Cancer
Authors: Fu Shuyu , Deng Hui , Bertolini Irene , Perego Michela , Chen Eric S. , Sanseviero Emilio , Mostafa Ali , Alicea-Torres Kevin , Garcia-Gerique Laura , Stone Erica L. , Kossenkov Andrew V. , Schug Zachary T. , Nam Brian , Mulligan Charles , Altieri Dario C. , Nefedova Yulia , Gabrilovich Dmitry I.
Published: April 2023

Supplemental Video
Supplementary legends from Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing
Authors: Chen Gregory M. , Chen Chia-Hui , Perazzelli Jessica , Grupp Stephan A. , Barrett David M. , Tan Kai
Published: April 2023

Legends for supplementary figures and tables.
Supplementary Figure 4 from Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade
Authors: Yan Bo , Hooper D. Craig , Yuan Zhiyong , Wang Changli , Chen Yulong , Lu Bo
Published: April 2023

Supplementary Figure 4
Supplementary Table 2 from Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity
Authors: Zheng Hong , Yu Xiaoqing , Ibrahim Mohammed L. , Foresman Dana , Xie Mengyu , Johnson Joseph O. , Boyle Theresa A. , Ruffell Brian , Perez Bradford A. , Antonia Scott J. , Ready Neal , Saltos Andreas N. , Cantwell Mark J. , Beg Amer A.
Published: April 2023

Supplementary Table 2
Supplementary Table 1 from Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity
Authors: Zheng Hong , Yu Xiaoqing , Ibrahim Mohammed L. , Foresman Dana , Xie Mengyu , Johnson Joseph O. , Boyle Theresa A. , Ruffell Brian , Perez Bradford A. , Antonia Scott J. , Ready Neal , Saltos Andreas N. , Cantwell Mark J. , Beg Amer A.
Published: April 2023

Supplementary Table 1